The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.
Prajapati K, Yan C, Yang Q, Arbitman S, Fitzgerald DP, Sharee S, Shaik J, Bosiacki J, Myers K, Paucarmayta A, Johnson DM, O'Neill T, Kundu S, Cusumano Z, Langermann S, Langenau DM, Patel S, Flies DB.
Prajapati K, et al.
Sci Adv. 2024 Mar;10(9):eadj4698. doi: 10.1126/sciadv.adj4698. Epub 2024 Mar 1.
Sci Adv. 2024.
PMID: 38427724
Free PMC article.